Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration

J Neurochem. 2007 Apr;101(2):342-54. doi: 10.1111/j.1471-4159.2006.04373.x.

Abstract

High glucose concentrations cause oxidative injury and programmed cell death in neurons, and can lead to diabetic neuropathy. Activating the type 3 metabotropic glutamate receptor (mGluR3) prevents glucose-induced oxidative injury in dorsal root ganglion neurons co-cultured with Schwann cells. To determine the mechanisms of protection, studies were performed in rat dorsal root ganglion neuron-Schwann cell co-cultures. The mGluR3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate prevented glucose-induced inner mitochondrial membrane depolarization, reactive oxygen species accumulation, and programmed cell death, and increased glutathione (GSH) concentration in co-cultured neurons and Schwann cells, but not in neurons cultured without Schwann cells. Protection was diminished in neurons treated with the GSH synthesis inhibitor l-buthionine-sulfoximine, suggesting that mGluR-mediated protection requires GSH synthesis. GSH precursors and the GSH precursor GSH-ethyl ester also protected neurons from glucose-induced injury, indicating that GSH synthesis in Schwann cells, and transport of reaction precursors to neurons, may underlie mGluR-mediated neuroprotection. These results support the conclusions that activating glial mGluR3 protects neurons from glucose-induced oxidative injury by increasing free radical scavenging and stabilizing mitochondrial function, through increased GSH antioxidant defense.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antimetabolites / toxicity
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Buthionine Sulfoximine / toxicity
  • Cells, Cultured
  • Coculture Techniques
  • Diabetic Neuropathies / metabolism
  • Diabetic Neuropathies / physiopathology
  • Excitatory Amino Acid Agonists / pharmacology
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism*
  • Ganglia, Spinal / physiopathology
  • Glucose / metabolism
  • Glucose / toxicity*
  • Glutathione / metabolism*
  • Hyperglycemia / metabolism
  • Hyperglycemia / physiopathology
  • Intracellular Space / metabolism
  • Mitochondrial Membranes / drug effects
  • Mitochondrial Membranes / metabolism
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / metabolism*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Receptors, Metabotropic Glutamate / agonists
  • Receptors, Metabotropic Glutamate / metabolism*
  • Schwann Cells / drug effects
  • Schwann Cells / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • Antimetabolites
  • Excitatory Amino Acid Agonists
  • Reactive Oxygen Species
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 3
  • Buthionine Sulfoximine
  • Glutathione
  • Glucose